3 assets in Ischemic Disease

Therapeutic assets addressing Ischemic Disease, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Tocilizumab Ischemic Disease	Zhujiang Hospital	P3	B (60)
Physiologic Sodium Chloride Solution Ischemic Disease	Zhujiang Hospital	P3	B (58)
Povidone-Iodine Ischemic Disease	Guangdong Provincial People's Hospital	N/A	D (30)